Paradoxical effect of Klebsiella pneumoniae OmpK36 porin deficiency

Pathology

Volumn 41, Issue 4, 2009, Pages 388-392

  Jiang, Xiuhong ^a,b   Espedido, Björn A ^a   Partridge, Sally R ^a   Thomas, Lee C ^a   Wang, Feng ^b   Iredell, Jonathan R ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b JILIN UNIVERSITY   (China)

Author keywords

AmpC; Antibiotic resistance; Klebsiella; OmpK; Porin

Indexed keywords

AMIKACIN; BACTERIAL PROTEIN; BETA LACTAMASE AMPC; CEFEPIME; CEFOTAXIME; CEFOXITIN; CIPROFLOXACIN; IMIPENEM; KANAMYCIN; LEVOFLOXACIN; OMPK 35 PROTEIN; OMPK 36 PROTEIN; PORIN; TIMENTIN; UNCLASSIFIED DRUG; AMPC BETA LACTAMASES; AMPC BETA-LACTAMASES; BETA LACTAMASE; OMPK36 PROTEIN, KLEBSIELLA PNEUMONIAE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; ESCHERICHIA COLI; GENE DELETION; HETEROZYGOSITY; HOMOLOGOUS RECOMBINATION; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLASMID; PROTEIN DEFICIENCY; WILD TYPE; ENZYMOLOGY; GENE INACTIVATION; GENETICS; MICROBIOLOGICAL EXAMINATION; MUTATION; POLYMERASE CHAIN REACTION;

BACTERIAL PROTEINS; BETA-LACTAMASES; DRUG RESISTANCE, MICROBIAL; GENE KNOCKOUT TECHNIQUES; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; MUTATION; PLASMIDS; POLYMERASE CHAIN REACTION; PORINS;

EID: 68849114014     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313020902908854     Document Type: Article

References (25)

1. Jacoby GA. AmpC beta-lactamases. Clin Microbiol Rev 2009; 22: 161-182
2. Hernandez-Alles S, Alberti S, Alvarez D, et al. Porin expression in clinical isolates of Klebsiella pneumoniae. Microbiology 1999; 145(pt 3): 673-679
3. Martinez-Martinez L, Pascual A, Hernandez-Alles S, et al. Roles of beta-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae. Antimicrob Agents Chemother 1999; 43: 1669-1673
4. Hernandez-Alles S, Conejo M, Pascual A, Tomas JM, Benedi VJ, Martinez-Martinez L. Relationship between outer membrane alterations and susceptibility to antimicrobial agents in isogenic strains of Klebsiella pneumoniae. J Antimicrob Chemother 2000; 46: 273-277
5. Livermore DM. b-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995; 8: 557-584
6. Lartigue MF, Zinsius C, Wenger A, Bille J, Poirel L, Nordmann P. Extended-spectrum beta-lactamases of the CTX-M type now in Switzerland. Antimicrob Agents Chemother 2007; 51: 2855-2860
7. Perez-Perez FJ, Hanson ND. Detection of plasmid-mediated AmpC b-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002; 40: 2153-2162
8. Valenzuela JK, Thomas L, Partridge SR, van der Reijden T, Dijkshoorn L, Iredell J. Horizontal gene transfer within a polyclonal outbreak of carbapenem-resistant Acinetobacter baumannii. J Clin Microbiol 2007; 45: 453-460
9. Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL, Threlfall EJ. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods 2005; 63: 219-228
10. Menard R, Sansonetti PJ, Parsot C. Nonpolar mutagenesis of the ipa genes de.nes IpaB, IpaC, and IpaD as e.ectors of Shigella .exneri entry into epithelial cells. J Bacteriol 1993; 175: 5899-5906
11. Ogunniyi AD, Kotlarski I, Morona R, Manning PA. Role of SefA subunit protein of SEF14 .mbriae in the pathogenesis of Salmonella enterica serovar Enteritidis. Infect Immunol 1997; 65: 708-717
12. Philippon A, Arlet G, Jacoby GA. Plasmid-determined AmpC-type b-lactamases. Antimicrob Agents Chemother 2002; 46: 1-11.
13. Zong Z, Partridge SR, Thomas L, Iredell JR. Dominance of blaCTXM within an Australian extended-spectrum beta-lactamase gene pool. Antimicrob Agents Chemother 2008; 52: 4198-4202
14. Bradford PA, Urban C, Mariano N, Projan SJ, Rahal JJ, Bush K. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein. Antimicrob Agents Chemother 1997; 41: 563-569
15. Cao VT, Arlet G, Ericsson BM, Tammelin A, Courvalin P, Lambert T. Emergence of imipenem resistance in Klebsiella pneumoniae owing to combination of plasmid-mediated CMY-4 and permeability alteration. J Antimicrob Chemother 2000; 46: 895-900.
16. Stapleton PD, Shannon KP, French GL. Carbapenem resistance in Escherichia coli associated with plasmid-determined CMY-4 betalactamase production and loss of an outer membrane protein. Antimicrob Agents Chemother 1999; 43: 1206-1210
17. Pages JM, James CE, Winterhalter M. The porin and the permeating antibiotic: A selective Diffusion barrier in Gram-negative bacteria. Nat Rev Microbiol 2008; 6: 893-903.
18. Espedido B, Iredell J, Thomas L, Zelynski A. Wide dissemination of a carbapenemase plasmid among gram-negative bacteria: Implications of the variable phenotype. J Clin Microbiol 2005; 43: 4918-4919
19. Martinez-Martinez L. Extended-spectrum beta-lactamases and the permeability barrier. Clin Microbiol Infect 2008; 14 (Suppl 1): 82-89
20. Domenech-Sanchez A, Martinez-Martinez L, Hernandez-Alles S, et al. Role of Klebsiella pneumoniae OmpK35 porin in antimicrobial resistance. Antimicrob Agents Chemother 2003; 47: 3332-3335
21. Bulychev A, Mobashery S. Class C beta-lactamases operate at the Diffusion limit for turnover of their preferred cephalosporin substrates. Antimicrob Agents Chemother 1999; 43: 1743-1746
22. Yoshimura F, Nikaido H. Diffusion of beta-lactam antibiotics through the porin channels of Escherichia coli K-12. Antimicrob Agents Chemother 1985; 27: 84-92.
23. Domenech-Sanchez A, Hernandez-Alles S, Martinez-Martinez L, Benedi VJ, Alberti S. Identification and characterization of a new porin gene of Klebsiella pneumoniae: Its role in beta-lactam antibiotic resistance. J Bacteriol 1999; 181: 2726-2732
24. Kaczmarek FM, Dib-Hajj F, Shang W, Gootz TD. High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of bla(ACT-1) beta-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin phoe. Antimicrob Agents Chemother 2006; 50: 3396-3406
25. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing: 18th Informational Supplement, M100-S18. Wayne, PA: Clinical and Laboratory Standards Institute, 2008.